RxDoctor Payments Data

Hollie Berryman, APRN

Family · Jefferson Hills, PANPI 1427601376

Payments from drug & device makers

$926in general payments, 2019–2025

Across 48 payments — averaging $19.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Heartflow, Inc.$130
  • Boehringer Ingelheim$96
  • E.r. Squibb & Sons, L.L.C.$87
  • AstraZeneca$87
  • Scpharmaceuticals Inc.$83
  • Amgen$77
  • plus $366 from 10 others

What the payments were for

  • Food & beverage$926100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$926 in reported general payments places this provider in the 70th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$8,750
Medicare patients
68
Services billed
111

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban136$133,170
XareltoRivaroxaban39$34,178
EntrestoSacubitril/Valsartan30$31,582
Repatha SureclickEvolocumab41$27,965
JardianceEmpagliflozin17$20,863
BrilintaTicagrelor12$7,712
Atorvastatin Calcium160$1,564
Metoprolol Succinate125$1,496
Ranolazine ErRanolazine15$1,406
Diltiazem 24hr Er (Cd)Diltiazem Hcl48$1,071
Rosuvastatin Calcium73$1,061
Carvedilol99$789
Flecainide Acetate26$602
Lisinopril84$598
Ezetimibe34$447

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$17$133,170136 claims
NovartisEntresto$51$31,58230 claims
Boehringer IngelheimJardiance$96$20,86317 claims
AstraZenecaBrilinta$87$7,71212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,717 family providers in Pennsylvania.

Other family in Jefferson Hills

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →